Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Roche Reprioritizes Pipeline, Kicks Leukemia and Lung Cancer Drug Med Back to Oryzon Genomics

Shares of Spanish biotech company Oryzon Genomics plummeted more than 23 percent after Swiss drug giant Roche ended a three-year-old developmental deal for the company’s leukemia and cancer treatments. 

Read More »

Ablynx signs Sanofi deal potentially worth up to $2.8 billion

French drugmaker Sanofi boosted its early-stage pipeline in immunology by signing a deal with Ablynx that could earn the Belgian biotech firm as much as 2.4 billion euros ($2.8 billion).

Read More »

Long work hours tied to irregular heart rhythm

People who typically work much more than 35 to 40 hours a week may be at heightened risk of developing atrial fibrillation, an irregular rapid heartbeat that can lead to strokes, heart failure and chronic fatigue, a recent study suggests.

Read More »

Belgian doctors pin hope on large brain collection to treat diseases

A psychiatric hospital in Belgium is home to one of the world’s largest collections of human brains, which researchers say could hold the key to developing new treatments for diseases such as psychosis, schizophrenia and severe depression.

Read More »

EU watchdog concerned drug agency EMA may be too close to companies

The European Medicines Agency (EMA), eager to accelerate access to promising new drugs, may be getting too cozy with the pharmaceutical companies it regulates.

Read More »

Siemens Breaks Ground on $300 Million Expansion in Walpole, Mass., Plans for 700 New Jobs

Siemens Healthineers broke ground on a $300 million expansion at its Massachusetts-based laboratory diagnostics, manufacturing and research and development facility. 

Read More »

Novartis Boss Updates Q2 2017 Financials, Reaffirms M&A Strategy

Novartis CEO Joe Jiminez spoke with investors and analysts regarding the company’s half-year financials.

Read More »

Senate Republicans reluctantly consider bipartisan healthcare talks

As their seven-year effort to repeal and replace Obamacare derailed in the U.S. Senate, Republicans faced the prospect of doing the once unthinkable: working with Democrats to make fixes to former President Barack Obama’s 2010 healthcare law.

Read More »

FDA Green Lights Gilead’s Vosevi; Black-Box Warning Attached

The FDA approved Gilead Sciences’ Vosevi, an oral medicine for the re-treatment of chronic HCV.

Read More »

Vertex Gains $8 Billion Overnight as Cystic Fibrosis Combo Drug Wows in Trials

Vertex Pharmaceuticals announced positive efficacy data from its Phase I and Phase II studies of three different triple combination regimens for cystic fibrosis patients,

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom